Literature DB >> 3099992

Cancer statistics, 1987.

E Silverberg, J Lubera.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3099992     DOI： 10.3322/canjclin.37.1.2

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  37 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Chart Audit of Mammography in a Family Practice: How to improve screening rates with a chart audit and outreach.

Authors:  J Yaphe; J Sangster; J Guthrie
Journal:  Can Fam Physician       Date:  1992-10       Impact factor: 3.275

3.  The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily.

Authors:  J K Heath; S J White; C N Johnstone; B Catimel; R J Simpson; R L Moritz; G F Tu; H Ji; R H Whitehead; L C Groenen; A M Scott; G Ritter; L Cohen; S Welt; L J Old; E C Nice; A W Burgess
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 4.  Management of early carcinoma of the ovary.

Authors:  G W Chapman
Journal:  J Natl Med Assoc       Date:  1988-09       Impact factor: 1.798

5.  Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.

Authors:  M Chackal-Roy; C Niemeyer; M Moore; B R Zetter
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

6.  Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.

Authors:  A M Joseph; T W Crowson; E C Rich
Journal:  J Gen Intern Med       Date:  1988 Mar-Apr       Impact factor: 5.128

7.  Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer.

Authors:  W H Cooner
Journal:  World J Urol       Date:  1993       Impact factor: 4.226

8.  Clearance kinetics and external dosimetry of 131I-labeled murine and humanized monoclonal antibody A33 in patients with colon cancer: radiation safety implications.

Authors:  Lawrence T Dauer; Daniel C Boylan; Matthew J Williamson; Jean St Germain; Steven M Larson
Journal:  Health Phys       Date:  2009-05       Impact factor: 1.316

9.  Telomerase activity in skeletal sarcomas.

Authors:  G Aue; B Muralidhar; H S Schwartz; M G Butler
Journal:  Ann Surg Oncol       Date:  1998 Oct-Nov       Impact factor: 5.344

10.  MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients.

Authors:  C Ramachandran; A Sauerteig; K S Sridhar; R J Thurer; A Krishan
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.